47217 Courses in Cardiff delivered On Demand

Comorbid GAD and Depression with CBT What is this webinar about? Around 60% of people with anxiety disorders have also have comorbid depression. We also know that people with anxiety disorders and co-occurring depression have higher overall symptom severity and worse outcomes compared to either alone. While training and textbooks focus almost exclusively on protocols for treating anxiety and depression is isolation, the reality in practical clinical settings is that many clients present with both conditions. This practical workshop will examine some key techniques to help clients work on their comorbid anxiety and depression. We will focus on key questions such as which should be treated first? How do we manage psychoeducation? What might be the most useful therapeutic goals in comorbid cases? What are the protocols for transdiagnostic approaches such as the Unified Protocol?  Key Topics (indicative) Comorbidty Where to start? Psychoeducation and Comorbidity Common pitfalls to avoid for the therapist working with comorbid conditions The Unified Protocol (Barlow) - practical aspects of implementation Working with Children and Young People with comorbid presentations - the three Pathways (Cummings) Case Study for discussion Summary and Next Steps

Reporting to the LA when your child is in burnout

You have deregistered your child and you know that unschooling is for you. But, what should you do first? Where do you start? And is it possible to reignite playful times in your child who has had less and less time to actually play since they began going to school? There are lots of things that you can do to move towards unschooling. This webinar concentrates on 5 steps to unschooling that will reconnect your child with their playful selves and provide a solid foundation for future learning.  This webinar is FREE for LPL Monthly Members along with a back catalogue of Unschooling Webinars, 2 live webinars a month, and discounts on coaching and mentoring services. Sign up for just £20 per month. Yes! I want to join the LPL Monthly Membership

Reporting to the LA when your child is in burnout

Full recording of the workshop: Couples Therapy - Beyond Foundations You will have access to the recording for 14 days. 

A clinical trial monitor acts on behalf of the sponsor to support investigational site personnel, verify the accuracy of data recorded, and ensure that the trial is conducted in compliance with the protocol, GCP and other study specific requirements. He or she acts as the ‘eyes and ears’ of the sponsor at the investigational site and provides the main channel of communication between sponsor and investigator. This short course explores the responsibilities of the monitor and provides insight into key challenges. We discuss assessment of investigators and investigational sites, education and trial initiation, monitoring of clinical conduct, including CRF review and source document verification, and trial close-out. We discuss noncompliance and how to deal with it.

New drug development requires major investment in capital, human resources and technical expertise. Strict adherence to regulations on testing and manufacturing standards is also required before a new drug can be marketed. One of the greatest challenges in conducting clinical trials is that of efficiency. As trials become more comprehensive, involving large numbers of participants globally, their duration is prolonged and costs increase. The longer trials last, the shorter is the patent life remaining after market approval and the longer patients must wait for the new product. This short course covers the key components of clinical trials and how these requirements interact with the drug development cycle.

Good Clinical Practice (GCP) is a set of internationally recognised ethical and scientific quality requirements for designing, conducting, recording and reporting clinical trials. Compliance with GCP principles is required by regulatory authorities in many countries for the authorisation of clinical trials and the acceptance of their data in applications for marketing approval. The International Council for Harmonisation's guideline E6, often referred to as ICH GCP, is the international standard specification for Good Clinical Practice. In this short course we describe the ICH’s role in the harmonisation of regulations, introduce its guideline E6, and set out the principles of GCP.

A clinical investigator is responsible for conducting the clinical trial in compliance with the study protocol, GCP, medical ethics, and applicable legal requirements. The clinical research community expects that investigators and clinical staff are fully trained in GCP. Duties and functions discussed in this short course include: provision of adequate resources; liaison with IRB/IEC; compliance with protocol; management of investigational product(s), informed consent and data records; and safety reporting.

Good Manufacturing Practice (GMP) is a set of rules for medicines manufacturers to follow so that their products are safe, effective, and of good quality. Everyone who works in a processing, quality control, packaging, or warehouse environment for a pharmaceutical or biotechnology company, or one of their contractors, must understand why GMP is important, how it applies to them, and how to comply with it. This short course explains what GMP is and why it is important, and it gives some lessons from history. It introduces the regulations and guidance documents that are the source of GMP rules. Finally, it touches on regulatory inspections and the consequences that can arise from failure to comply with GMP requirements.